研究対象者の権利と補償:−グローバル臨床試験を視野に入れた国際比較と今後の課題

千絵子 栗原, 栗原 千絵子 · Institutional Repositories DataBase (IRDB) · 2011

Objectives:To identify characteristics of compensation frameworks for research-related injuries of humansubjects of clinical trials, in Japan and other parts of the world, and clarify future perspectives.Method:Narrative, non-systematic review of regulations and literature concerning compensationprograms for research-related injuries of Japan, United States (US), and European, Asian, and Africancountries, and additional interview surveys.Results:(1) There is a substantial diversity in the national frameworks for compensation for researchrelatedinjuries. (2) Analysis of cost-effectiveness and feasibility of insurance program is difficult when it ismanaged as a private and/or voluntary system. (3) The compensation guidelines of the JapanPharmaceutical Industry Legal Affairs Association provide a high level of human subject protectioncompared with the world situation. The compensation guidelines of the Association of BritishPharmaceutical Industries, which is similar to the Japanese guidelines, seem to work as global standards tosome extent. On the other hand, the compensation policy development and implementation is insufficientin comparison with the international standards and those in the US and other Asian countries.Conclusion:A publicly established framework would work better for cost-effective analysis towardfairness of compensation for research-related injuries. Additionally, a global consensus for fairness andequality of compensation should be reached through more international discussion on this topic.

Cited by 0 works.

Authors